Pharmaceutical Raw Materials
Veterinary API
Antiallergic Drugs
Hormones and Endocrine Drugs
Drug Metabolism
Pharmaceutical Intermediates
Synthetic Anti Infective Drugs
Specialty Drugs
Vitamins and Minerals Medicines
Feed Drug Additive
Antineoplastic Agents
Nervous System Drugs
Respiratory Drugs
Diagnostic Agents
Anti Stress Drugs
Antipyretic Analgesics
Antiparasitic Drugs
Circulatory System Drugs
Biochemicals
Blood System Drugs
Immune System Medication
Pharmaceutical Excipients
Fluid, Electrolyte, and Acid-Base Balance
Urinary System Drugs
Antibiotics
Anesthetic Agents
Inhibitors
Other Chemical Drugs
Digestive System Drugs
CAS:63527-52-6
Molecular Formula:C16H17N5O7S2
Alias
More Information
Cefotaxima Acid; (6R,7R)-3-[(Acetyl-Oxy)Methyl]-7-[[(2Z)-(2-Amino-4-Thiazolyl)(Methoxyimino)-Acetyl]Amino]-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid; 5-Thia-1-Azabicyclo[4.2.0]Oct-2-Ene-2-Carboxylic Acid, 3-[(Acetyloxy)Methyl]-7-[[(2Z)-(2-Amino-4-Thiazolyl)(Methoxyimino)Acetyl]Amino]-8-Oxo-, (6R,7R)-
Brief Introduction
This product is a kind of semi synthetic oxime cephalosporin, which is a pharmaceutical raw material and used as an antibacterial drug.
Alias
More Information
Aquex; Brinaldix; Dt-327; Clopamidum; Chlosudimeprimyl; Adurix; 4-Chloro-N-[(2R,6S)-2,6-Dimethylpiperidin-1-Yl]-3-Sulfamoylbenzamide; Clopamidum
Brief Introduction
Clopamide is a thiazide diuretic with oral activity, which can inhibit the sodium coupled chloride cotransporter SLC12A3. Clopamide can be used in the study of hypertension and heart failure.
CAS:63610-08-2
Molecular Formula:C18H17NO3
Alias
More Information
Ibustrin; Indobufen; 2-[4-(1-Oxo-1,3-Dihydro-Isoindol-2; 2-[4-(1-Oxo-1,3-Dihydro-Isoindol-2-Yl)-Phenyl]-Butyric Acid; 2-(4-(1-Oxoisoindolin-2-Yl)Phenyl)Butanoic Acid; K-3920; Unii-6T9949G4Lz; Indobufen (Inn); 2-(4-(1-Oxo-2-Isoindolinyl)Phenyl)Butyric Acid
Brief Introduction
Indobufen is an anti platelet aggregation drug. It can selectively act on circulating platelets, block thrombosis, inhibit the release of platelet factors and play an anti platelet aggregation role. This inhibition is reversible, does not change plasma parameters, does not damage platelet function, and returns abnormal platelet function to normal. It can significantly improve the microcirculation parameters and walking distance of patients with peripheral vascular disease and intermittent claudication. It has the same effect as aspirin and dipyridamole in preventing obstruction after coronary artery shunt and femoral artery shunt; During hemodialysis, it can significantly reduce platelet deposits on the dialysis membrane. This product can also prevent secondary thrombosis after transient ischemic attack or mild stroke. Compared with similar drugs, indobufen inhibits platelet factor, and its anti platelet aggregation effect is 2 ~ 5 times that of salicylic acid, with slightly shorter bleeding time. Compared with ticlopidine, there was no significant difference in oral clinical efficacy, but indobufen showed good tolerance.
CAS:63619-84-1
Molecular Formula:C30H31NO3
Brief Introduction
Trioxifene is a nonsteroidal selective estrogen receptor modulator (SERM) with potential antineoplastic activity. Trioxifene competes with estradiol in binding to estrogen receptor alpha (ER alpha), thereby inhibiting ER alpha-mediated signal transduction and gene expression. In addition, trioxifene exerts intrinsic estrogenic activity depending on the tissue. Clinical development of trioxifene has not been preceded due to its side effect profile and lack of increased efficacy over tamoxifen.
Alias
More Information
(+/-)-1-{P-[2-(Cyclopropylmethoxy) Ethyl] Phenoxy}-3-Isopropylamino-2-Propanol; Betaxololum; 1-[4-[2-(Cyclopropylmethoxy)Ethyl]Phenoxy]-3-[(1-Methylethyl)Amino]-2-Propanol; Betaxolol [Inn:Ban]; Kerlone; Betaxolol (Tn); 1-[4-[2-(Cyclopropylmethoxy)Ethyl]Phenoxy]-3-(Propan-2-Ylamino)Propan-2-Ol; 1-{4-[2-(Cyclopropylmethoxy)-Ethyl]-Phenoxy}-3-Isopropylamino-Propan-2-Ol; Betoptic; Betaxololum [Inn-Latin]; Betazolol
Brief Introduction
Cardiac selectivity β- Adrenergic receptor blockers have no endogenous sympathetic effect and have weak membrane stability. It is clinically used for the treatment of moderate hypertension.
Inquiry (
10
/ 10
)
Clear All
Sign In
Error!